113
Participants
Start Date
November 27, 2017
Primary Completion Date
July 17, 2023
Study Completion Date
June 30, 2025
SBRT
SBRT dose and fractionation dependent on site of metastasis and proximity to critical normal tissues.
TKI
Continued background TKI alone
Oncology Institute of Southern Switzerland, Bellinzona
UniversitatsSpital Zurich, Zurich
Kantonsspital St. Gallen, Sankt Gallen
Ospedale San Luigi Gonzaga - Universita Di Torino, Torino
Institut Claudius Régaud, Toulouse
University Hospital Virgen del Rocio, Seville
Institut Gustave Roussy, Paris
Policlinico Universitario Campus Bio-Medico, Roma
Hospital Clinic Universitari de Barcelona, Barcelona
Institut Català d'Oncologia, Barcelona
Hopital Cantonal Universitaire De Geneve, Geneva
Royal Marsden Hosital, Sutton
Royal Marsden Hospital, Chelsea
Royal Surrey County Hospital, Guildford
Belfast City Hospital, Belfast
Bristol Haematology and Oncology Centre, Bristol
Western General Hospital, Edinburgh
Beatson West of Scotland Cancer Centre, Glasgow
Castle Hill Hospital, Hull
Leicester Royal Infirmary, Leicester
St Bartholomew's Hospital, London
University College London Hospital, London
Guy's Hospital, London
The Christie Hospital, Manchester
Clatterbridge Cancer Centre, Metropolitan Borough of Wirral
Nottingham City Hospital, Nottingham
Churchill Hospital, Oxford
Weston Park Hospital, Sheffield
Southampton University Hospital, Southampton
Institute of Cancer Research, United Kingdom
OTHER